iRhythm has an FDA warning letter over Zio AT quality systems
IRhythm stock is down today on news of an FDA warning letter involving its Zio AT mobile cardiac telemetry device.
Stay updated with breaking news from Massdevice Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IRhythm stock is down today on news of an FDA warning letter involving its Zio AT mobile cardiac telemetry device.
Medtronic stock continues to decline today — a day after it underwhelmed The Street with its growth projection for its new fiscal year.
Better Therapeutics (Nasdaq:BTTX) shares fell today after its second-quarter earnings report included a wide-ranging business update.
Embecta (Nasdaq:EMBC) shares ticked up today on second-quarter results that topped the consensus forecast, leading to a guidance increase.
Steris (NYSE:STE) reported fourth-quarter results that exceeded Wall Street's expectations while upping guidance for the year ahead.